News Drug Pipeline for Macular Degeneration in Focus at AAO by Medscape • 2018/10/19 • 0 Comments Updates from phase 3 trials of VEGF inhibitors for neovascular age-related macular degeneration, and a novel genetic treatment, will be highlighted at the American Academy of Ophthalmology meeting. Medscape Medical News Full Story →